|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||
|
||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sA840E224-38AF-11EF-A442-D9AB84CE164B&I=39IZM&T=&OP=Display&O=html&O1=12694349&O2=1000000000755031&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DNitroxoline%2520impairs%2520tumor%2520progression%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520regulating%2520cathepsin%2520B%2520activity%26rft.au%3DButinar%252C%2520Miha%26rft.au%3DMarkelc%252C%2520Bo%25C5%25A1tjan%26rft.au%3DMirkovi%25C4%2587%252C%2520Bojana%26rft.au%3DMitrovi%25C4%2587%252C%2520Ana%26rft.date%3D2015-08-07%26rft.eissn%3D1949-2553%26rft.epage%3D19042%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issue%3D22%26rft.jtitle%3DOncotarget%26rft.spage%3D19027%26rft.volume%3D6%26rft_id%3Dinfo%253Adoi%252F10.18632%252Foncotarget.3699%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,4-MISCELLANEOUS_FREE_EJOURNALS-getFullTxt-object,5-GFMER_FREE_MEDICAL_JOURNALS-getFullTxt-object,6-PUBMED_CENTRAL_OPEN_ACCESS_FREE-getFullTxt-object,7-COBIB_SI_LCL-getHolding-object,8-DOI-getDOI-object,9-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,10-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,11-REFWORKS_EXPORT_TOOL-getReference-object,12-SHERPA_RoMEO_LCL-getWebService-object,13-GOOGLE_SCHOLAR_FREE-getWebSearch-object,14-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.253732&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12694349-sA840E224-38AF-11EF-A442-D9AB84CE164B" timestamp="2024-07-02T22:14:17Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000755031</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Nitroxoline impairs tumor progressionin vitroandin vivoby regulating cathepsin B activity</jnl:atitle>
<jnl:jtitle>Oncotarget</jnl:jtitle>
<jnl:date>2015-08-07</jnl:date>
<jnl:spage>19027</jnl:spage>
<jnl:epage>19042</jnl:epage>
<jnl:issn>1949-2553</jnl:issn>
<jnl:volume>6</jnl:volume>
<jnl:issue>22</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1949-2553</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:8af1a6bd48a886b9dc78c4dd73488337c883cc63</ctx:identifier>
<ctx:identifier>urn:UUID:sA840E224-38AF-11EF-A442-D9AB84CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)